Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Thought Leadership
Latest Report
Biopharma Quarterly Round Up (Q3 2021)
This article pack, produced by the editorial team at Evaluate Vantage, explores the key developments and decisions that are impacting the biopharma landscape. Access your complimentary copy for actionable intelligence on regulatory shifts, M&A activity, dealmaking trends, market events and more.
Report library
Covid Round Up (2021)
The biopharma and medtech sectors have been racing to deliver treatments, vaccines and other solutions to Covid-19 for close to two years now. What progress has been made…
European Society of Medical Oncology Conference (ESMO) 2021
Conducted as a virtual event from 16 to 21 September, ESMO 2021 brought together an international community of experts across disciplines. Once again, this oncology…
2021 IASLC World Conference on Lung Cancer
The year-end oncology congress season kicked off with the annual IASLC World Conference on Lung Cancer. While it took place in virtual format from September 8-14, this…
Evaluate Vantage SPAC article pack Sept 2021
Special purpose acquisition companies, known as Spacs or “blank check companies”, are not new but have recently rocketed in popularity as a vehicle for going public…
Biopharma and Medtech Half-Year Review 2021
Despite the continuing pandemic, the biopharma sector saw a return to relative stability during the first half of 2021. Remote operations are proving effective, deals are…
